Botulinum toxin type A (Allergan)

N/A

Report date: 2026/02/14 20:00:22

Base Information

Drug NameBotulinum toxin type A (Allergan)
Drug Alias NameAGN-151607AGN-151607-DP
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsHernia, VentralAtrial FibrillationStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHernia, VentralAtrial FibrillationStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A